Gyrate atroph gene therapy (National Institutes of Health)
N/A
Report date: 2023/02/04 20:21:20
Base Information
Drug NameGyrate atroph gene therapy (National Institutes of Health)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCentral State University Of New York IncNational Institutes Of Health
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthCentral State University Of New York Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A